Biote 预计 2026 年营收将超过 1.75 亿美元，调整后 EBITDA 超过 2500 万美元，因召回导致的业务中断推迟了疗程增长 (NASDAQ:BTMD)
· seekingalpha.com
Biote (BTMD) 2026 年第二季度财报电话会议回顾：召回影响、下调指引、疗程量恢复计划、补充剂业务增长以及并购前景——阅读关键信息...
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...